This blog explores lung cancer survival rates across different stages and highlights how access to early diagnosis and advanced U.S. treatments—such as targeted therapies and immunotherapy—can significantly improve outcomes. It also explains how Medebound HEALTH supports international patients, especially from Asia, in consulting U.S. lung cancer experts and accessing clinical trials or travelling for care.